Company Contents
Quick Facts & Snapshot
Summary
The global Apheresis Equipment market is entering a robust expansion phase, driven by rising plasma therapies, transfusion safety norms, and automation needs. Leading Apheresis Equipment market companies consolidate share through integrated platforms, service contracts, and digital upgrades, supporting growth from US$ 2.78 Billion in 2025 to US$ 4.61 Billion by 2032 at a 7.40% CAGR.
Source: Secondary Information and ReportMines Research Team - 2026
Ranking Methodology
Rankings of Apheresis Equipment market companies are based on a composite score integrating quantitative and qualitative criteria. Core inputs include estimated 2025 apheresis equipment revenue, three-year growth trajectory, and installed base across hospitals, blood centers, and plasma-collection networks. We also assess technology differentiation such as automation level, cross-therapy versatility, software integration, and connectivity features. Portfolio breadth, including disposables and services, and global service coverage with uptime guarantees materially influence scores. Additional weight is assigned to the ability to win multi-year framework agreements, execute long-term maintenance contracts, and support regulatory compliance in highly scrutinized markets. Strategic moves—M&A, partnerships, digital health initiatives, and clinical evidence generation—are reviewed to gauge future competitiveness. Each factor is normalized into a 100-point model, peer-benchmarked, and synthesized into a final ranking that reflects both current scale and forward-looking strength.
Top 10 Companies in Apheresis Equipment
Source: Secondary Information and ReportMines Research Team - 2026
Detailed Company Profiles
Fresenius SE & Co. KGaA (Fresenius Kabi)
Global healthcare group and leading supplier of apheresis systems, disposables, and services for plasma collection and therapeutic applications.
Haemonetics Corporation
Specialized blood-management and apheresis technology company focused on plasma, whole-blood automation, and perioperative blood conservation.
Terumo BCT, Inc.
Global leader in therapeutic apheresis and cell processing, serving oncology, neurology, and cell-therapy centers with integrated platforms.
Asahi Kasei Medical Co., Ltd.
Diversified medical business with strong specialization in blood purification and selective therapeutic apheresis technologies.
B. Braun Melsungen AG
Large medtech player integrating apheresis options into renal and critical-care platforms for hospitals worldwide.
Kawasumi Laboratories Inc.
Japanese manufacturer specializing in high-quality apheresis disposables, blood bags, and related consumables.
Nikkiso Co., Ltd.
Technology company focused on dialysis and blood purification systems, incorporating apheresis functionalities for critical-care settings.
Kaneka Corporation
Innovator in lipoprotein apheresis and immunoadsorption systems serving cardiology and autoimmune segments.
Macopharma SA
European supplier of apheresis disposables, blood bags, and transfusion solutions for blood centers and hospitals.
Cerus Corporation
Specialty company focused on pathogen reduction for blood components, increasingly integrated into apheresis workflows.
SWOT Leaders
Fresenius SE & Co. KGaA (Fresenius Kabi)
SWOT Snapshot
Extensive global installed base, comprehensive portfolio, strong service infrastructure, and long-term plasma-center partnerships.
Complex corporate structure and broad portfolio can dilute focus on breakthrough apheresis innovation and speed of execution.
Rising global demand for plasma-derived therapies and hospital outsourcing of service contracts for critical equipment.
Pricing pressure from competitors, tightening procurement rules, and potential disruptions in raw-material and disposable supply chains.
Haemonetics Corporation
SWOT Snapshot
Deep specialization in blood management, strong software and analytics stack, and high loyalty among large plasma networks.
High exposure to plasma market cycles and donor-availability trends, with limited diversification across other modalities.
Global expansion into emerging markets and increased adoption of automation in blood centers and donation workflows.
Competitive launches of next-generation plasma systems and risk of commoditization in high-volume disposables segments.
Terumo BCT, Inc.
SWOT Snapshot
Strong clinical reputation in therapeutic apheresis, broad modality coverage, and integration with cell and gene therapy workflows.
Complex systems requiring intensive training, potentially slowing adoption in resource-constrained hospitals and smaller centers.
Rapid expansion of cellular immunotherapies and demand for sophisticated apheresis platforms in oncology and transplant centers.
Emerging cell-therapy technologies, budget constraints in hospitals, and regional competitors with lower-cost alternatives.
Apheresis Equipment Market Regional Competitive Landscape
North America remains the largest and most profitable region, underpinned by dense plasma-collection networks, stringent blood safety regulations, and high hospital procedure volumes. Fresenius Kabi, Haemonetics Corporation, Terumo BCT, and Cerus dominate key accounts, while payers increasingly scrutinize cost per procedure, encouraging automation and efficiency-focused innovation among Apheresis Equipment market companies.
Europe shows steady demand driven by aging populations, neurology and autoimmune indications, and robust public blood services. Fresenius Kabi, Terumo BCT, Macopharma, and Kaneka are prominent, supported by strong distributor networks. Procurement is tender-driven, favoring Apheresis Equipment market companies that combine competitive pricing, proven clinical evidence, and reliable regional service coverage.
Asia-Pacific is the fastest-growing region, with Japan, China, India, and Southeast Asia expanding plasma collection and therapeutic apheresis capacity. Terumo BCT, Asahi Kasei Medical, Nikkiso, Kawasumi, and Fresenius Kabi gain share as governments upgrade hospital infrastructure. Local manufacturing, training, and tailored disposables offerings are central differentiators for Apheresis Equipment market companies in this region.
Latin America and the Middle East & Africa represent smaller but increasingly strategic markets, supported by donor-safety initiatives and modernization of tertiary hospitals. B. Braun, Fresenius Kabi, Macopharma, and Nikkiso leverage established critical-care and dialysis footprints. Apheresis Equipment market companies that offer flexible financing, turnkey training, and rugged systems gain advantage in budget-constrained settings.
In high-income Asia, particularly Japan and South Korea, clinical sophistication and reimbursement frameworks favor advanced therapeutic apheresis modalities. Asahi Kasei Medical, Kaneka, Nikkiso, Terumo BCT, and Kawasumi lead, with selective adsorption and lipoprotein apheresis seeing increased adoption. Collaboration with academic centers is a key strategy for Apheresis Equipment market companies seeking guideline inclusion and indication expansion.
Apheresis Equipment Market Emerging Challengers & Disruptive Start-Ups
Emerging Challengers & Disruptive Start-Ups
Cloud-native analytics platform that ingests real-time data from diverse apheresis devices to optimize scheduling, predict consumable demand, and reduce donor chair time.
Developing compact, energy-efficient apheresis systems aimed at decentralized plasma collection in smaller clinics and mobile donation units.
Specialized in next-generation adsorption cartridges targeting autoimmune and inflammatory mediators, designed to retrofit major existing apheresis consoles.
Cost-optimized therapeutic apheresis platform combining robust hardware with low-cost disposables for emerging-market hospitals and regional blood centers.
Donor engagement and telehealth platform integrating with apheresis systems to personalize donation intervals and improve donor retention and safety.
Apheresis Equipment Market Future Outlook & Key Success Factors (2026-2032)
From 2025 to 2031, cumulative investments in metro expansions and station safety upgrades are projected to surpass significant amounts. The total market will scale from US$ 2.27 Billionin 2025 to US$ 3.38 Billion by 2031, reflecting a 6.90% CAGR. Winning Apheresis Equipment market companies will share several attributes. First, they will embed native IoT sensors, enabling predictive maintenance contracts that can double recurring revenue within five years. Second, modular design philosophies—interchangeable panels, plug-and-play controllers—will shorten installation windows and appeal to cost-sensitive public operators.
Localization strategies will also define competitive edges. Suppliers that establish regional assembly plants to meet content rules in India, Brazil, or the U.S. are likely to capture bonus points in tenders. Finally, sustainability credentials will move from optional to mandatory. Recyclable composite panels, energy-efficient brushless motors, and life-cycle carbon disclosures will become bid differentiators. In short, the coming decade rewards Apheresis Equipmentmarket companies that marry digital intelligence with manufacturing agility and regulatory foresight.
Frequently Asked Questions
Find answers to common questions about this company report.